Rezulin was prescribed to approximately 1.9 million American diabetics before being pulled from the market in 2000 after the prescription medicine was linked to at least 63 deaths from liver failure. Numerous lawsuits were filed on behalf of those who died or suffered serious liver problems from taking this drug.
Pfizer Inc. has now resolved all but three of 35,000 claims related to Rezulin for a total of about $750 million. Pfizer, which is acquiring rival Wyeth for almost $64 billion, paid about $500 million to settle Rezulin cases consolidated in federal court in New York. The company also paid another $250 million to resolve suits filed in state courts.
In 2001, a Texas jury ordered Pfizer to pay $43 million to a 63-year-old diabetic who suffered liver damage while taking the drug. That case was subsequently settled for $30 million. In 2002, an Oklahoma jury ordered the drug maker to pay $11.6 million in damages to the family of a man who died after taking Rezulin. That award later was upheld on appeal.
Our firm represented over 5,000 Rezulin victims and we settled all of our clients’ claims in early 2004. We are pleased to have been able to help those clients and their families reach a resolution of their claims.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.